Sign inGet started

ROWLAND LLOYD A

Insider CIK 1236395 · XNCR Sr. V.P. and General Counsel · CTMX General Counsel · AMLN VP, Chief Compliance Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CTMX CytomX Therapeutics, Inc. S Sale2025-03-182025-03-2010,203$0.60 $6.1K120,594SEC↗
CTMX CytomX Therapeutics, Inc. M Exercise deriv2024-08-202024-08-2211,250— $00SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2024-08-202024-08-224,181$1.23 $5.1K130,797SEC↗
CTMX CytomX Therapeutics, Inc. M Exercise2024-08-202024-08-2211,250— $0134,978SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2024-03-192024-03-215,268$2.09 $11.0K117,728SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2024-01-182024-01-1975,000— $075,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2024-01-182024-01-19100,000— $0100,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award2024-01-182024-01-1925,000— $0122,996SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2023-12-202023-12-224,077$1.38 $5.6K97,996SEC↗
CTMX CytomX Therapeutics, Inc. M Exercise deriv2023-12-172023-12-1911,250— $011,250SEC↗
CTMX CytomX Therapeutics, Inc. M Exercise2023-12-172023-12-1911,250— $0102,073SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2023-09-222023-09-225,486$1.30 $7.1K80,609SEC↗
CTMX CytomX Therapeutics, Inc. A Award2023-09-202023-09-2215,000— $086,095SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2023-03-162023-03-202,037$1.98 $4.0K71,095SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2023-02-022023-02-0675,000— $075,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2023-02-022023-02-0675,000— $075,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award2023-02-022023-02-0625,000— $073,132SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2022-08-102022-08-1222,500— $022,500SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2022-08-102022-08-12135,000— $0135,000SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2022-07-202022-07-215,602$1.42 $8.0K43,689SEC↗
CTMX CytomX Therapeutics, Inc. A Award2022-07-192022-07-2115,000— $049,291SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2022-02-022022-02-04135,000— $0135,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award2022-02-022022-02-0422,500— $034,291SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2021-10-242021-10-2630,000— $030,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2021-10-242021-10-2640,000— $040,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2021-02-262021-03-02125,000— $0125,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2020-02-142020-02-19100,000— $0100,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award2019-05-312019-06-041,812$8.21 $14.9K11,791SEC↗
CTMX CytomX Therapeutics, Inc. P Buy2019-03-042019-03-059,000$10.33 $93.0K9,979SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2019-01-252019-01-2954,900— $054,900SEC↗
CTMX CytomX Therapeutics, Inc. A Award2018-11-302018-12-06979$11.73 $11.5K979SEC↗
XNCR Xencor Inc A Award deriv2016-01-262016-01-2820,000— $020,000SEC↗
XNCR Xencor Inc J Other2015-12-152015-12-211,501— $01,501SEC↗
XNCR Xencor Inc A Award deriv2015-03-042015-03-2025,000— $025,000SEC↗
XNCR Xencor Inc A Award deriv2015-02-122015-02-1312,500— $012,500SEC↗
XNCR Xencor Inc A Award deriv2014-08-292014-09-0260,000— $060,000SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-106,250$31.00 $193.8K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-105,000$31.00 $155.0K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-107,802$31.00 $241.9K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-105,251$31.00 $162.8K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-107,081$31.00 $219.5K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-104,482$31.00 $138.9K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-101,953$31.00 $60.5K1,000SEC↗
AMLN AMYLIN PHARMACEUTICALS INC H Expire deriv2012-08-082012-08-101,563— $00SEC↗
AMLN AMYLIN PHARMACEUTICALS INC H Expire deriv2012-08-082012-08-103,201— $00SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-1018,750$31.00 $581.3K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-1011,000$31.00 $341.0K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-1012,198$31.00 $378.1K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-1028,649$31.00 $888.1K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-1012,919$31.00 $400.5K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-1032,113$31.00 $995.5K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-1030,405$31.00 $942.6K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-1017,047$31.00 $528.5K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC H Expire deriv2012-08-082012-08-1023,437— $00SEC↗
AMLN AMYLIN PHARMACEUTICALS INC H Expire deriv2012-08-082012-08-1026,799— $00SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-101,767$31.00 $54.8K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other deriv2012-08-082012-08-1010,000$31.00 $310.0K1,767SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other2012-08-082012-08-10473$31.00 $14.7K3,192SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other2012-08-082012-08-103,192$31.00 $98.9K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other2012-08-082012-08-106,614$31.00 $205.0K1,360SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other2012-08-082012-08-101,360$31.00 $42.2K0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other2012-08-082012-08-10412$31.00 $12.8K35,014SEC↗
AMLN AMYLIN PHARMACEUTICALS INC J Other2012-08-082012-08-1035,014$31.00 $1.09M0SEC↗
AMLN AMYLIN PHARMACEUTICALS INC A Award2012-07-252012-07-26823$14.62 $12.0K35,426SEC↗
AMLN AMYLIN PHARMACEUTICALS INC S Sale2012-03-292012-03-293,000$25.00 $75.0K34,603SEC↗
AMLN AMYLIN PHARMACEUTICALS INC M Exercise deriv2012-03-282012-03-295,000$22.83 $114.1K18,750SEC↗
AMLN AMYLIN PHARMACEUTICALS INC S Sale2012-03-282012-03-295,000$22.83 $114.1K37,603SEC↗
AMLN AMYLIN PHARMACEUTICALS INC M Exercise2012-03-282012-03-295,000$9.02 $45.1K42,603SEC↗
AMLN AMYLIN PHARMACEUTICALS INC A Award deriv2012-03-062012-03-077,802— $07,802SEC↗
AMLN AMYLIN PHARMACEUTICALS INC A Award deriv2012-03-062012-03-0712,198— $012,198SEC↗
AMLN AMYLIN PHARMACEUTICALS INC A Award2012-03-062012-03-076,700— $037,603SEC↗
AMLN AMYLIN PHARMACEUTICALS INC A Award2012-03-062012-03-071,529— $07,974SEC↗
AMLN AMYLIN PHARMACEUTICALS INC A Award deriv2012-03-012012-03-021,767— $011,767SEC↗
AMLN AMYLIN PHARMACEUTICALS INC D To issuer2012-03-012012-03-021,767— $030,903SEC↗
AMLN AMYLIN PHARMACEUTICALS INC A Award deriv2012-02-222012-02-245,000— $010,000SEC↗
AMLN AMYLIN PHARMACEUTICALS INC A Award deriv2012-02-082012-02-105,000— $05,000SEC↗
AMLN AMYLIN PHARMACEUTICALS INC D To issuer2012-02-082012-02-105,000— $032,009SEC↗